Sign In
Buy ARGX
$813.14
+10.97 (+1.37%)
At Close: Jun 03, 2026
SEMrush (SEMR) to Report Q4 Earnings: What's in the Cards?
02:02pm, Friday, 25'th Feb 2022 Zacks Investment Research
SEMrush's (SEMR) fourth-quarter 2021 performance is likely to have benefited from growth in user licenses per customer along with strength in product add-ons.
Steven Cohen's Interest in IDEAYA Increases
10:23am, Friday, 25'th Feb 2022
Steven Cohen (Trades, Portfolio), leader of Point72 Asset Management, disclosed earlier this week he increased his stake in IDEAYA Biosciences Inc. ( IDYA , Financial) by 52.12%.
argenx to Report Full Year 2021 Financial Results and Fourth Quarter Business Update on March 3, 2022
06:00am, Thursday, 24'th Feb 2022 GlobeNewswire Inc.
February 24, 2022Breda, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today an
argenx to Report Full Year 2021 Financial Results and Fourth Quarter Business Update on March 3, 2022
01:00am, Thursday, 24'th Feb 2022
February 24, 2022 Breda, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today a
argenx to Present at the 11th Annual SVB Leerink Global Healthcare Conference
01:00am, Thursday, 10'th Feb 2022
February 10, 2022 Breda, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today a
12 biotech stocks to consider buying now as prospects for the sector brighten this year
02:01pm, Monday, 07'th Feb 2022 MarketWatch
Biotechnology is so beaten down, relative valuation metrics suggest some stocks could more than double.
12 biotech stocks to consider buying now as prospects for the sector brighten this year
04:53pm, Sunday, 06'th Feb 2022
Biotechnology is so beaten down, relative valuation metrics suggest some stocks could more than double
The Daily Biotech Pulse: Novavax COVID Shot Authorized In Australia, Zymeworks Restructures, Orphan Drug Designation For Marker's Pancreatic Cancer Drug
01:28pm, Thursday, 20'th Jan 2022 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
Eisai Announces Publication Of Positive Data On Lenvima-Keytruda Combo In Endometrial Cancer
Eisai Co.
argenx to Present at 40th Annual J.P. Morgan Healthcare Conference
06:00am, Monday, 03'rd Jan 2022 GlobeNewswire Inc.
January 3, 2022Breda, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today anno
argenx to Present at 40th Annual J.P. Morgan Healthcare Conference
01:00am, Monday, 03'rd Jan 2022
January 3 , 202 2 Breda, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today a
argenx SE to Post FY2021 Earnings of ($8.04) Per Share, Piper Sandler Forecasts (NASDAQ:ARGX)
06:24am, Friday, 24'th Dec 2021 Dakota Financial News
argenx SE (NASDAQ:ARGX) Equities research analysts at Piper Sandler increased their FY2021 earnings per share estimates for shares of argenx in a note issued to investors on Monday, December 20th. Piper Sandler analyst E. Tenthoff now expects that the company will earn ($8.04) per share for the year, up from their prior estimate of []
argenx: Vyvgart's Approval A Key Step For Continued Value Creation
10:15am, Wednesday, 22'nd Dec 2021
argenx received FDA approval for Vyvgart (efgartigimod) for the treatment of generalized myasthenia gravis. The label looks very favorable, and the only negative is that patients who do not have AChR
H.C. Wainwright Stick to Their Buy Rating for Argenx Se By Investing.com
07:13am, Tuesday, 21'st Dec 2021 Investing.com
H.C. Wainwright Stick to Their Buy Rating for Argenx Se
Is Argenx a Good Biotech Stock to Buy for 2022?
11:59am, Monday, 20'th Dec 2021 The Motley Fool
The recent approval of this drugmaker's first product is giving reasons to cheer now, but what about down the road?
A Peek Into The Markets: US Stock Futures Signal Lower Start On Wall Street; Crude Oil Down 4%
10:48am, Monday, 20'th Dec 2021 Benzinga
Pre-open movers
U.S. stock futures traded lower in early pre-market trade after the Dow Jones tumbled more than 500 points in the previous session. The Federal Reserve, last week, said it will be acce
